Kymera Therapeutics (KYMR) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to $71.7 million.
- Kymera Therapeutics' Shares Outstanding rose 1080.02% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.7 million, marking a year-over-year increase of 1080.02%. This contributed to the annual value of $64.9 million for FY2024, which is 1673.98% up from last year.
- Kymera Therapeutics' Shares Outstanding amounted to $71.7 million in Q3 2025, which was up 1080.02% from $70.6 million recorded in Q2 2025.
- Kymera Therapeutics' 5-year Shares Outstanding high stood at $71.7 million for Q3 2025, and its period low was $44.9 million during Q1 2021.
- In the last 5 years, Kymera Therapeutics' Shares Outstanding had a median value of $55.4 million in 2023 and averaged $57.3 million.
- Per our database at Business Quant, Kymera Therapeutics' Shares Outstanding skyrocketed by 217143.84% in 2021 and then soared by 99.19% in 2023.
- Kymera Therapeutics' Shares Outstanding (Quarter) stood at $51.5 million in 2021, then increased by 6.8% to $55.0 million in 2022, then rose by 0.99% to $55.6 million in 2023, then increased by 16.74% to $64.9 million in 2024, then rose by 10.56% to $71.7 million in 2025.
- Its last three reported values are $71.7 million in Q3 2025, $70.6 million for Q2 2025, and $65.1 million during Q1 2025.